Johns Hopkins
Aspergillus
Influenza
Legionella
MRSA
Neisseria Meningitidis
NUTI
Pertussis
Rotavirus
RSV
Tuberculosis
VISA
VRE
VZV
HEIC Infectious Diseases
  Prevention and Control Surveillance Research Microbiology Services Outbreak Management
  Education Disease Exposures Infectious Diseases Patient and Visitor Information
Antibiotic Management Program
Heic Forum
Who's at HEIC
Home

Neisseria Meningitidis

Meningococcal Infections: The Ongoing Saga

Chemoprophylaxis for Health Care Workers Exposed to N. meningitidis

by Trish M. Perl, MD, MSc

Rationale:

• 1.3 to 5.8% “secondary” cases result from exposure to a N. meningitidis case

•  the attack rate in persons exposed to a case with close contact (i.e. household) is 500 to 800 times that of the general population

• up to 85% of persons with “close” contact carry N. meningitidis in their oropharynx after exposure to a case whereas 5-11% of persons living in crowded conditions carry N. meningitidis in the oropharynx.

• In general, hospital personnel have the same risk of developing disease as the general population unless they have contact with respiratory secretions.  However, disease in health care workers is rare and thought to be in part due to patient isolation and treatment that decrease the chance of becoming a carrier.

 

A prophylactic agent must

          • be safe

          • eliminate carriage rapidly and for a prolonged period

          • achieve bactericidal concentrations in saliva and tears

          • cost effective

          • limit change of antimicrobial resistance

 

In the health care setting, an agent also should be

          • practical (to assure compliance)

 

Review of the literature: see attached sheet

          • Sulfonamides are no longer used because of wide spread drug resistance.

 

References:

Pusley, Dworzack, Horowitz et al.. Efficacy of Ciprofloxacin in the treatment of nasopharyngeal carriers of N. Meningitidis JID 1987:211-213.

Pusley, Dworzack, Roccaforte et al.. An Open study of the efficacy of a single dose of Ciprofloxacin in eliminating the chronic nasopharyngeal carriage of N. Meningitidis JID 1988 157:852-3.

Gutter, Beaty.  Minocycline in the chemoprophylaxis of meningococcal disease. AAC 1972397-402

Gaunt, Lambert.  Single dose of Ciprofloxacin for the eradication of pharynceal carriage of N. Meningitidis.  J Antimicrob Chemother 1988 21:489-96.

Judson, Ehret. Single dose ceftriaxone to eradicate pharyngeal N. Meningitidis  Lancet 1984.22/29:1462-3.

Devine, Johnson, Hagerman etal.  The effect of minocycline on meningococcal nasopharyngeal carrier state in naval personnel.  Am J Epidemiol 1971;93:337-45


 
Efficacy
Side Effects
Resistance
Dose
Cost
Comments
Rifampin
75-90%
colored secretions
efficacy of BCP
25%side effects
10%
300 BID
2 days
$11.58
Red book & CDC recommendation contraindicated in pregnancy
Ceftriaxone
97%
pain at injection
none reported
250 mg
$7.76
Use in pregnancy
Ciprofloxacin
93%
none reported
not reported
500 mg
$3.24
> 16 yrs
contraindicated in pregnancy
eradicates 75% of chronic carriers
Minocycline
84%
33% vertigo
67%
200mg load
100 BID X 5d
$68.40
experience in outbreaks

 Top of page